BAYER AG
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Public
- Established
- 1863-08-01
- Employees
- 99.7K
- Market Cap
- $30.1B
- Website
- http://www.bayer.com
ZK 230211 in Postmenopausal Woman With Metastatic Breast Cancer
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-11-09
- Last Posted Date
- 2014-10-10
- Lead Sponsor
- Bayer
- Target Recruit Count
- 68
- Registration Number
- NCT00555919
BENEFIT Extension Study
- First Posted Date
- 2007-10-16
- Last Posted Date
- 2012-03-05
- Lead Sponsor
- Bayer
- Target Recruit Count
- 283
- Registration Number
- NCT00544037
ZK283197 for Treatment of Vasomotor Symptoms
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-10-01
- Last Posted Date
- 2015-04-09
- Lead Sponsor
- Bayer
- Target Recruit Count
- 116
- Registration Number
- NCT00537836
Levonorgestrel Contraceptive Intrauterine Systems (LCS) Pearl Index Study
- First Posted Date
- 2007-09-12
- Last Posted Date
- 2017-01-25
- Lead Sponsor
- Bayer
- Target Recruit Count
- 2885
- Registration Number
- NCT00528112
Efficacy and Safety of Primovist in Chinese Patients
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-09-10
- Last Posted Date
- 2015-05-01
- Lead Sponsor
- Bayer
- Target Recruit Count
- 234
- Registration Number
- NCT00526188
SH L 562BB Phase II/III Dose Justification and Gadoteridol-controlled Comparative Study
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-08-30
- Last Posted Date
- 2017-08-28
- Lead Sponsor
- Bayer
- Target Recruit Count
- 165
- Registration Number
- NCT00522951
Endometrial Safety Study
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-08-30
- Last Posted Date
- 2014-12-31
- Lead Sponsor
- Bayer
- Target Recruit Count
- 662
- Registration Number
- NCT00522873
Capadenoson in Angina Pectoris
Phase 2
Withdrawn
- Conditions
- Interventions
- First Posted Date
- 2007-08-21
- Last Posted Date
- 2011-01-13
- Lead Sponsor
- Bayer
- Registration Number
- NCT00518921
SH T00186 Phase II/ III Optimal Drospirenone (DRSP) Dose Finding and Placebo-controlled Comparative Study
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-08-06
- Last Posted Date
- 2017-01-26
- Lead Sponsor
- Bayer
- Target Recruit Count
- 249
- Registration Number
- NCT00511797
A Study to Assess the Efficacy and Safety of Enteric-Coated Acetylsalicylic Acid in Patients at Moderate Risk of Cardiovascular Disease
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-07-13
- Last Posted Date
- 2018-10-26
- Lead Sponsor
- Bayer
- Target Recruit Count
- 12546
- Registration Number
- NCT00501059
- Locations
- 🇺🇸
PharmaTrials, Inc., Perth Amboy, New Jersey, United States
🇺🇸Merit Medical Group, Inc., Richlands, Virginia, United States
🇺🇸Medical Research Trust, Boynton Beach, Florida, United States
© Copyright 2024. All Rights Reserved by MedPath